Articles and Blogs

Despite acknowledging “weighty” constitutional questions, the Fifteenth Court of Appeals in Texas (the “Court”) refused to halt a Medicaid qui tam action against Novartis, holding that the company’s constitutional challenges to the Texas Medicaid Fraud Prevention Act (“TMFPA”) must be addressed through ordinary appellate review, rather than through extraordinary relief. In re Novartis Pharmaceuticals... READ MORE